0001415889-23-012417.txt : 20230818 0001415889-23-012417.hdr.sgml : 20230818 20230818204007 ACCESSION NUMBER: 0001415889-23-012417 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230816 FILED AS OF DATE: 20230818 DATE AS OF CHANGE: 20230818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Frankenfield Christopher James CENTRAL INDEX KEY: 0001988344 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40925 FILM NUMBER: 231187103 MAIL ADDRESS: STREET 1: C/O XILIO THERAPEUTICS, INC. STREET 2: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xilio Therapeutics, Inc. CENTRAL INDEX KEY: 0001840233 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851623397 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-833-1027 MAIL ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4-08182023_080801.xml X0508 4 2023-08-16 0001840233 Xilio Therapeutics, Inc. XLO 0001988344 Frankenfield Christopher James 828 WINTER STREET, SUITE 300 WALTHAM MA 02451 false true false false CHIEF OPERATING OFFICER 0 Stock Option (right to buy) 2.785 2023-08-16 4 A 0 300000 0 A 2033-08-15 Common Stock 300000 300000 D The option award was granted on August 16, 2023 and shall vest with respect to 1/3 of the shares of common stock underlying the stock option on the first anniversary of the grant date and with respect to the remaining 2/3 of the shares of common stock underlying the stock option on the second anniversary of the grant date. /s/ Kevin Brennan, Attorney-in-Fact 2023-08-18